C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease
- 13 January 2005
- journal article
- research article
- Published by Wiley in Cell Biochemistry and Function
- Vol. 24 (1), 87-90
- https://doi.org/10.1002/cbf.1206
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery DiseaseCirculation, 1997
- Genetic Polymorphism of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) as a Risk Factor for Coronary Artery DiseaseCirculation, 1997
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJama-Journal Of The American Medical Association, 1995
- Serum Total Homocysteine and Coronary Heart DiseaseInternational Journal of Epidemiology, 1995
- Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly PopulationJAMA, 1993
- Hyperhomocysteinaemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences?QJM: An International Journal of Medicine, 1993
- Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemiaThe American Journal of Clinical Nutrition, 1993
- Effect of vitamin B-6 deficiency on fasting plasma homocysteine concentrationsThe American Journal of Clinical Nutrition, 1992
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseThe New England Journal of Medicine, 1991
- Homocysteinemia due to folate deficiencyMetabolism, 1987